Publications by authors named "Isabel Boivin"

Claim this Profile
C
CD33 epitope editing unlocks UM171-expanded cord blood grafts for AML immunotherapy.
Bernhard Lehnertz, Maéva Langouët, Sophie Corneau, Tara MacRae, Maju Joe, Isabel Boivin

Mol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DDB1 engagement defines the selectivity of S656 analogs for cyclin K degradation over CDK inhibition.
Céline Moison, Rodrigo Mendoza-Sanchez, Deanne Gracias, Doris A Schuetz, Jean-François Spinella, Isabel Boivin

EMBO Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.
Arnaud Métois, Marie-Eve Bordeleau, Louis Theret, Azadeh Hajmirza, Ossama Moujaber, Isabel Boivin

Biomark Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.
Safia Safa-Tahar-Henni, Karla Páez Martinez, Verena Gress, Nayeli Esparza, Élodie Roques, Isabel Boivin

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapeutic targeting of surfaceome heterogeneity in AML.
Marie-Eve Bordeleau, Éric Audemard, Arnaud Métois, Louis Theret, Véronique Lisi, Isabel Boivin

Cell Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DELE1 haploinsufficiency causes resistance to mitochondrial stress-induced apoptosis in monosomy 5/del(5q) AML.
Jean-François Spinella, Jalila Chagraoui, Céline Moison, Vincent P Lavallée, Isabel Boivin

Leukemia· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.
Céline Moison, Deanne Gracias, Julie Schmitt, Simon Girard, Jean-François Spinella, Isabel Boivin

Sci Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMGA2 expression defines a subset of human AML with immature transcriptional signature and vulnerability to G2/M inhibition.
Céline Moison, Jean-François Spinella, Jalila Chagraoui, Vincent-Philippe Lavallée, Bernhard Lehnertz, Isabel Boivin

Blood Adv· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vesicular trafficking is a key determinant of the statin response in acute myeloid leukemia.
Jana Krosl, Marie-Eve Bordeleau, Céline Moison, Tara MacRae, Isabel Boivin

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLF expression defines the human hematopoietic stem cell state.
Bernhard Lehnertz, Jalila Chagraoui, Tara MacRae, Elisa Tomellini, Sophie Corneau, Isabel Boivin

Blood· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML.
Laura Simon, Jean-François Spinella, Chi-Yuan Yao, Vincent-Philippe Lavallée, Isabel Boivin

Blood· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic characterization of ABT-199 sensitivity in human AML.
Richard Bisaillon, Céline Moison, Clarisse Thiollier, Jana Krosl, Marie-Eve Bordeleau, Isabel Boivin

Leukemia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia.
Irène Baccelli, Yves Gareau, Bernhard Lehnertz, Stéphane Gingras, Jean-François Spinella, Isabel Boivin

Cancer Cell· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex karyotype AML displays G2/M signature and hypersensitivity to PLK1 inhibition.
Céline Moison, Vincent-Philippe Lavallée, Clarisse Thiollier, Bernhard Lehnertz, Isabel Boivin

Blood Adv· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
mutations promote context-dependent transformation in acute myeloid leukemia with alterations.
Bernhard Lehnertz, Yu Wei Zhang, Isabel Boivin, Nadine Mayotte, Elisa Tomellini

Blood· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors.
Vincent-Philippe Lavallée, Jana Krosl, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Isabel Boivin

Blood· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature.
Vincent-Philippe Lavallée, Sébastien Lemieux, Geneviève Boucher, Patrick Gendron, Isabel Boivin

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.
Caroline Pabst, Anne Bergeron, Vincent-Philippe Lavallée, Jonathan Yeh, Patrick Gendron, Isabel Boivin

Blood· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of VCH-759 monotherapy in hepatitis C infection.
Curtis Cooper, Eric J Lawitz, Peter Ghali, Maribel Rodriguez-Torres, Frank H Anderson, Isabel Boivin

J Hepatol· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis